Alaunos Therapeutics (TCRT) Short Interest Ratio & Short Volume $2.64 +0.10 (+3.94%) As of 01:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisChartCompetitorsEarningsInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alaunos Therapeutics Short Interest DataAlaunos Therapeutics (TCRT) has a short interest of 46,500 shares, representing 3.42% of the float (the number of shares available for trading by the public). This marks a -42.38% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 135,793 shares to cover all short positions.Current Short Interest46,500 sharesPrevious Short Interest80,700 sharesChange Vs. Previous Month-42.38%Dollar Volume Sold Short$113,925.00Short Interest Ratio0.1 Days to CoverLast Record DateApril 30, 2025Outstanding Shares1,640,000 sharesFloat Size1,360,000 sharesShort Percent of Float3.42%Today's Trading Volume6,955 sharesAverage Trading Volume135,793 sharesToday's Volume Vs. Average5% Short Selling Alaunos Therapeutics? Sign up to receive the latest short interest report for Alaunos Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTCRT Short Interest Over TimeTCRT Days to Cover Over TimeTCRT Percentage of Float Shorted Over Time Alaunos Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202546,500 shares $113,925.00 -42.4%3.4%0.1 $2.45 4/15/202580,700 shares $234,030.00 +75.4%6.1%0.2 $2.90 3/31/202546,000 shares $67,160.00 -11.0%3.3%0.1 $1.46 3/15/202551,700 shares $73,936.17 -12.5%3.8%3.1 $1.43 2/28/202559,100 shares $91,605.00 +8.8%4.3%2.7 $1.55 2/15/202554,300 shares $87,966.00 -17.4%3.9%2.2 $1.62 1/31/202565,700 shares $111,690.00 +21.0%4.8%2.5 $1.70 1/15/202554,300 shares $96,654.00 -50.0%3.9%2.1 $1.78 12/31/2024108,500 shares $206,150.00 -18.5%7.9%4.5 $1.90 12/15/2024133,100 shares $252,890.00 +3.8%9.6%5.7 $1.90 Get the Latest News and Ratings for TCRT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alaunos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/30/2024128,200 shares $330,756.00 -7.7%9.3%5.2 $2.58 11/15/2024138,900 shares $290,301.00 -0.3%10.1%7.2 $2.09 10/31/2024139,300 shares $285,565.00 +5.3%10.1%7 $2.05 10/15/2024132,300 shares $292,383.00 +1.2%9.6%6.6 $2.21 9/30/2024130,700 shares $420,854.00 +3.7%9.5%5.4 $3.22 9/15/2024126,100 shares $293,813.00 -9.7%9.1%6.3 $2.33 8/31/2024139,700 shares $361,823.00 +3.5%10.1%8.5 $2.59 8/15/2024135,000 shares $317,250.00 -6.3%9.8%9.1 $2.35 7/31/2024144,100 shares $534,611.00 +8.1%10.4%12.2 $3.71 7/15/2024133,300 shares $903,774.00 -2.7%9.7%14 $6.78 6/30/20241,370,000 shares $957,630.00 -2.1%10.0%32.4 $0.70 6/15/20241,400,000 shares $1.29 million -1.4%10.2%31 $0.92 5/31/20241,420,000 shares $1.55 million -2.1%10.3%30.4 $1.09 5/15/20241,450,000 shares $1.73 million -1.4%10.5%23 $1.19 4/30/20241,470,000 shares $1.85 million +0.7%9.6%20.6 $1.26 4/15/20241,460,000 shares $2.04 million -4.0%9.5%12.5 $1.40 3/31/20241,520,000 shares $2.75 million -1.9%9.9%7.9 $1.81 3/15/20241,550,000 shares $2.65 million -6.1%10.1%6.4 $1.71 2/29/20241,650,000 shares $3.45 million -0.6%10.7%4.6 $2.09 2/15/20241,660,000 shares $2.64 million -2.9%10.8%4.3 $1.59 1/31/20241,710,000 shares $4.32 million -7.1%11.2%3.9 $2.53 1/15/202427,530,000 shares $4.45 million +1.9%12.0%4 $0.16 12/31/202327,020,000 shares $1.91 million +20.1%11.8%4.2 $0.07 12/15/202322,500,000 shares $1.02 million -5.0%9.8%4.5 $0.05 11/30/202323,690,000 shares $1.57 million +5.9%10.3%7.1 $0.07 11/15/202322,380,000 shares $1.68 million -6.9%9.7%7.2 $0.08 10/31/202324,040,000 shares $1.92 million +3.8%10.5%7.8 $0.08 10/15/202323,170,000 shares $2.55 million +0.0%10.1%9.8 $0.11 9/30/202323,160,000 shares $3.05 million -2.0%10.1%10.9 $0.13 9/15/202323,630,000 shares $2.98 million -2.7%10.3%11.7 $0.13The DOJ Just Said Your Money Isn’t Yours (Ad)What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what the Department of Justice just admitted in court—claiming cash isn't legally your property. What does that mean? It means Washington thinks they can seize, freeze, or drain your accounts—whenever they want.Get your free guide now by clicking here >> 8/31/202324,290,000 shares $3.42 million -5.5%10.6%13.4 $0.14 8/15/202325,710,000 shares $3.57 million -1.6%11.2%14.9 $0.14 7/31/202326,140,000 shares $11.30 million +1.2%11.4%49.3 $0.43 7/15/202325,820,000 shares $12.14 million -0.1%11.8%48.4 $0.47 6/30/202325,840,000 shares $13.18 million +1.0%11.8%47.5 $0.51 6/15/202325,580,000 shares $12.28 million +2.5%11.7%45.9 $0.48 5/31/202324,950,000 shares $12.45 million +4.8%11.4%40.3 $0.50 5/15/202323,810,000 shares $15.48 million -0.3%11.0%38.1 $0.65 4/30/202323,880,000 shares $13.61 million +0.4%11.1%38.3 $0.57 4/15/202323,780,000 shares $13.55 million +1.2%11.0%35.9 $0.57 3/31/202323,500,000 shares $14.81 million +1.7%10.9%30.4 $0.63 3/15/202323,110,000 shares $11.50 million -1.9%10.7%24.6 $0.50 2/28/202323,560,000 shares $13.08 million +0.0%10.9%21.6 $0.56 2/15/202323,550,000 shares $15.07 million -2.2%10.9%17.6 $0.64 1/31/202324,090,000 shares $17.79 million -0.4%11.2%16.3 $0.74 1/15/202324,180,000 shares $19.28 million -7.3%11.1%15.7 $0.80 12/30/202226,070,000 shares $16.92 million -5.9%12.0%15.2 $0.65 12/15/202227,690,000 shares $17.05 million -11.5%12.8%14.1 $0.62 11/30/202231,290,000 shares $19.96 million -1.3%14.5%9.4 $0.64 11/15/202231,700,000 shares $32.33 million -1.4%16.2%8.6 $1.02 10/31/202232,160,000 shares $36.98 million +9.4%16.3%8.5 $1.15 10/15/202229,390,000 shares $32.04 million +1.1%14.9%7.5 $1.09 9/30/202229,070,000 shares $50.00 million +3.8%14.9%7.6 $1.72 9/15/202228,000,000 shares $59.08 million -3.6%14.4%6.8 $2.11 8/31/202229,050,000 shares $71.46 million +0.0%14.9%9 $2.46 8/15/202229,040,000 shares $56.63 million -3.7%14.9%9.8 $1.95 7/31/202230,150,000 shares $35.28 million +4.4%15.5%10.1 $1.17 7/15/202228,870,000 shares $38.11 million No Change14.8%8.9 $1.32 TCRT Short Interest - Frequently Asked Questions What is Alaunos Therapeutics' current short interest? Short interest is the volume of Alaunos Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 46,500 shares of TCRT short. 3.42% of Alaunos Therapeutics' shares are currently sold short. Learn More on Alaunos Therapeutics' current short interest. What is a good short interest percentage for Alaunos Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.42% of Alaunos Therapeutics' floating shares are currently sold short. Is Alaunos Therapeutics' short interest increasing or decreasing? Alaunos Therapeutics saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 46,500 shares, a decline of 42.4% from the previous total of 80,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Alaunos Therapeutics' float size? Alaunos Therapeutics currently has issued a total of 1,640,000 shares. Some of Alaunos Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Alaunos Therapeutics currently has a public float of 1,360,000 shares. How does Alaunos Therapeutics' short interest compare to its competitors? 3.42% of Alaunos Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Alaunos Therapeutics: Leap Therapeutics, Inc. (7.19%), AlloVir, Inc. (2.56%), Allarity Therapeutics, Inc. (10.88%), Cingulate Inc. (5.46%), GeoVax Labs, Inc. (5.89%), X4 Pharmaceuticals, Inc. (7.59%), Cocrystal Pharma, Inc. (0.01%), Flora Growth Corp. (1.50%), Trinity Biotech plc (0.92%), Eterna Therapeutics Inc. (0.55%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Spotify Technology S.A. ($4.67 billion), Charter Communications, Inc. ($4.58 billion), Capital One Financial Co. ($4.47 billion), The Kroger Co. ($2.56 billion), Reddit, Inc. ($2.23 billion), Rivian Automotive, Inc. ($2.16 billion), Live Nation Entertainment, Inc. ($1.90 billion), SoFi Technologies, Inc. ($1.85 billion), Zscaler, Inc. ($1.75 billion), and Omnicom Group Inc. ($1.75 billion). View all of the most shorted stocks. What does it mean to sell short Alaunos Therapeutics stock? Short selling TCRT is an investing strategy that aims to generate trading profit from Alaunos Therapeutics as its price is falling. TCRT shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Alaunos Therapeutics? A short squeeze for Alaunos Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TCRT, which in turn drives the price of the stock up even further. How often is Alaunos Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TCRT, twice per month. The most recent reporting period available is April, 30 2025. More Short Interest Resources from MarketBeat Related Companies Leap Therapeutics Short Interest AlloVir Short Interest Allarity Therapeutics Short Interest Cingulate Short Interest GeoVax Labs Short Interest X4 Pharmaceuticals Short Interest Cocrystal Pharma Short Interest Flora Growth Short Interest Trinity Biotech Short Interest Eterna Therapeutics Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TCRT) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredAI Bloodbath Coming on June 1st?If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alaunos Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alaunos Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TCRT Stock Free TCRT Stock Alerts